kabutan

Nxera Pharma surges to daily limit, operating profit reaches 3.244 billion yen in Q1

Thu May 7, 2026 9:47 am JST Catalyst

Nxera Pharma Co., Ltd. <4565> surged to its daily limit, hitting a new year-to-date high. The company announced its consolidated financial results for the first quarter (January-March) of fiscal year ending December 2026 after the close of trading on the 1st. Investors welcomed the news that operating profit turned to a profit of 3.244 billion yen (compared to a loss of 2.193 billion yen in the same period last year).

Revenue increased 69.4% year-on-year to 11.256 billion yen. The main driver was the achievement of 7 milestones (compared to 1 in the same period last year). In addition, focused narrowing of research and development areas and cost reduction efforts led to decreases in R&D expenses and selling, general and administrative expenses, contributing to improved profitability. The company has left its full-year earnings forecast unchanged.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles